A preliminary disease severity score for juvenile systemic sclerosis

Arthritis and Rheumatism

Volumn 64, Issue 12, 2012, Pages 4143-4150

  La Torre, Francesco ^a   Martini, Giorgia ^a   Russo, Ricardo ^b   Katsicas, Maria Marta ^b   Corona, Fabrizia ^c   Calcagno, Giuseppina ^d   Falcini, Fernanda ^e   Vittadello, Fabio ^a   Zulian, Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; DEATH; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; JUVENILE SYSTEMIC SCLEROSIS; JUVENILE SYSTEMIC SCLEROSIS SEVERITY SCORE; MALE; MEDSGER SEVERITY SCORE; ORGAN SYSTEMS; PEDIATRIC SEVERITY SCORE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; SYSTEMIC SCLEROSIS;

ARGENTINA; AUTOANTIBODIES; CHILD; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84870354772     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34652     Document Type: Article

References (21)

1. Zulian F, Martini G,. Childhood systemic sclerosis. Curr Opin Rheumatol 2007; 19: 592-7. (Pubitemid 47530880)
2. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281-5.
3. Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999; 26: 2159-67. (Pubitemid 29487010)
4. Geirsson AJ, Wollheim FE, Akesson A,. Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale. Ann Rheum Dis 2001; 60: 1117-22. (Pubitemid 33099994)
5. Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W,. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003; 21: S42-6.
6. Herrick AL, Ennis H, Bhushan M, Silman AJ, Baildam EM,. Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care Res (Hoboken) 2010; 62: 213-8.
7. Zulian F, Woo P, Athreya BH, Laxer RM, Medsger TA Jr, Lehman TJ, et al, for the Pediatric Rheumatology European Society/American College of Rheumatology/European League Against Rheumatism Ad Hoc Committee on Classification Criteria for Juvenile Systemic Sclerosis. The Pediatric Rheumatology European Society/American College of Rheumatology/European League Against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum 2007; 57: 203-12. (Pubitemid 47164080)
8. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 2006; 29: 581-93. (Pubitemid 44446267)
9. Kliegman RM, Behrman RE, Jenson HB, Stanton BF,. Table 715.6 Nelson textbook of pediatrics. 18th ed. Philadelphia: Elsevier-Saunders; 2009. p. 2944.
10. Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, et al, in cooperation with the Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. Arthritis Rheum 1999; 42: 2213-9. (Pubitemid 30263608)
11. Kliegman RM, Behrman RE, Jenson HB, Stanton BF,. Nelson textbook of pediatrics. 18th ed. Philadelphia: Elsevier-Saunders; 2009. p. 2164.
12. Delbecq AL, Van de Ven AH, Gustafson DH,. Group techniques for program planning: a guide to nominal group and Delphi processes. Glenview (IL): Scott, Foresman; 1975.
13. De Wolf D,. Clinical practice: pulmonary hypertension in children. Eur J Pediatr 2009; 168: 515-2.
14. Cohen J,. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20: 37-46.
15. Martini G, Foeldvari I, Russo R, Cuttica R, Eberhard A, Ravelli A, et al, for the Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum 2006; 54: 3971-8. (Pubitemid 44955901)
16. Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol 2006; 33: 1004-13.
17. Suarez-Almazor ME, Catoggio LJ, Maldonado-Cocco JA, Cuttica R, Garcia-Morteo O,. Juvenile progressive systemic sclerosis: clinical and serologic findings. Arthritis Rheum 1985; 28: 699-702. (Pubitemid 15059082)
18. Lababidi HM, Nasr FW, Khatib Z,. Juvenile progressive systemic sclerosis: report of five cases. J Rheumatol 1991; 18: 885-8.
19. Clements PJ,. Measuring disease activity and severity in scleroderma. Curr Opin Rheumatol 1995; 7: 517-21.
20. Medsger TA Jr,. Assessment of damage and activity in systemic sclerosis. Curr Opin Rheumatol 2000; 12: 545-58.
21. Medsger TA Jr,. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status and psychologic well-being. Rheum Dis Clin North Am 2003; 29: 255-73, vi. (Pubitemid 36765120)